Core Viewpoint - The law firm Brodsky & Smith is investigating potential claims against the Board of Directors of Exact Sciences Corporation for possible breaches of fiduciary duty related to its acquisition by Abbott for $105.00 per share, totaling approximately $21 billion [1][2]. Group 1 - The investigation focuses on whether the Exact Sciences Board failed to conduct a fair process and whether the acquisition deal provides fair value to shareholders [2]. - The acquisition price of $105.00 per share represents a total equity value of around $21 billion [1]. Group 2 - Brodsky & Smith is a litigation law firm with expertise in representing shareholders in securities and class action lawsuits, having successfully recovered millions for clients [4]. - The firm offers to discuss the legal ramifications of the investigation with shareholders of Exact Sciences without obligation or cost [3].
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS)